Skip to main content

How Adenosine Converts Atrial Flutter to Atrial Fibrillatiom

 

Adenosine: Mechanism of Action and Its Role in Atrial Flutter – Including Conversion to Atrial Fibrillation with AV Block



---


Introduction


Adenosine is a naturally occurring purine nucleoside widely used in cardiology for the diagnosis and termination of supraventricular tachycardias (SVTs). While it is highly effective in AV node–dependent tachycardias such as AVNRT and AVRT, its role in atrial flutter is primarily diagnostic rather than therapeutic.


Understanding its electrophysiologic effects is crucial, especially because adenosine can occasionally convert atrial flutter into atrial fibrillation with transient AV block — a phenomenon that can alarm clinicians if not anticipated.



---


Cellular and Electrophysiologic Mechanism of Adenosine


Adenosine acts via specific G-protein–coupled receptors:


A1 receptors (cardiac effects – most important clinically)


A2A receptors (coronary vasodilation)


A2B and A3 (less relevant in arrhythmia management)



1. Action on the AV Node


In the heart, adenosine binds to A1 receptors in the AV node and:


Inhibits adenylate cyclase → ↓ cAMP


Reduces calcium influx (L-type Ca²⁺ channels)


Increases outward potassium current (IK-Ado)


Causes membrane hyperpolarization



Net Electrophysiologic Effects:


Slows AV nodal conduction velocity


Increases AV nodal refractoriness


Produces transient complete AV block


Suppresses triggered activity



Its plasma half-life is less than 10 seconds, making its effects rapid and short-lived.



---


Why Adenosine Terminates Some Tachycardias but Not Atrial Flutter


Terminates:


AVNRT


AVRT


Other AV node–dependent reentrant tachycardias



These arrhythmias require the AV node as a critical part of the reentry circuit.


Does NOT Terminate:


Atrial flutter


Atrial fibrillation


Atrial tachycardia



Because these arrhythmias originate and sustain within atrial tissue and are independent of the AV node.



---


Atrial Flutter: Mechanism Overview


Typical atrial flutter is a macro-reentrant circuit, most commonly cavotricuspid isthmus–dependent in the right atrium.


Atrial rate: ~250–350 bpm


Ventricular rate: Often 150 bpm (2:1 AV conduction)


ECG: Sawtooth flutter waves (especially in inferior leads)



Since the AV node is not part of the reentrant circuit, blocking it does not terminate flutter — it only affects ventricular response.



---


What Happens When Adenosine Is Given in Atrial Flutter?


Step 1: AV Node Suppression


Adenosine causes:


Increased AV block (e.g., 2:1 → 4:1)


Sometimes transient complete AV block



This unmasks flutter waves and clarifies diagnosis.


This is why adenosine is extremely useful in regular narrow-complex tachycardia when flutter with 2:1 conduction mimics sinus tachycardia.



---


Conversion of Atrial Flutter to Atrial Fibrillation After Adenosine


Although uncommon, adenosine can convert atrial flutter into atrial fibrillation.


Proposed Mechanisms:


1. Shortening of atrial refractory period



2. Increased spatial dispersion of refractoriness



3. Enhanced atrial vulnerability



4. Heterogeneous conduction during transient AV nodal suppression




Adenosine increases atrial electrophysiologic instability by activating potassium currents in atrial tissue, which may:


Destabilize the organized macro-reentrant flutter circuit


Promote wavebreak


Lead to chaotic atrial activation (atrial fibrillation)




---


ECG Appearance After Adenosine


You may observe:


Sudden irregular atrial activity


Loss of organized flutter waves


Irregularly irregular rhythm


High-degree or transient complete AV block


Pause followed by AF with slow ventricular response



Because adenosine suppresses AV conduction simultaneously, the ECG may show:


Atrial fibrillation with high-degree AV block


This is typically transient due to adenosine’s ultra-short half-life.



---


Clinical Implications


1. Diagnostic Utility


Adenosine helps differentiate:


Sinus tachycardia


Atrial flutter with 2:1 block


AVNRT


AVRT



2. Not a Therapeutic Strategy for Flutter


It does not terminate typical flutter.


Definitive treatments include:


Electrical cardioversion


Rate control (beta blockers, non-DHP CCBs)


Catheter ablation (cavotricuspid isthmus ablation)



3. Caution


In patients with:


Pre-excited atrial fibrillation


Severe bronchospasm


Significant conduction disease



Adenosine must be used carefully.



---


Key Takeaways


Adenosine acts on A1 receptors → AV nodal hyperpolarization.


It terminates AV node–dependent tachycardias.


In atrial flutter, it increases AV block but does not terminate the arrhythmia.


It may rarely convert flutter to atrial fibrillation.


Resulting ECG may show atrial fibrillation with transient high-degree AV block.


Its primary role in flutter is diagnostic.




---


Clinical Pearl


If a regular narrow-complex tachycardia at 150 bpm does not terminate with adenosine but reveals flutter waves during transient AV block — think atrial flutter with 2:1 conduction.


Understanding this mechanism prevents misinterpretation and inappropriate management decisions.


Comments

Popular posts from this blog

How to Measure PR Interval

PR Interval on ECG – Measurement and Clinical Significance How to Measure PR Interval on ECG? Definition: PR interval is measured from the beginning of the P wave to the beginning of the QRS complex. Step-by-step method: 1. Use Lead II (usually best P wave visibility). 2. Identify: Onset of P wave Onset of QRS complex (first deflection – Q or R) 3. Count small boxes between them. ECG Paper Speed: 25 mm/s 1 small box = 0.04 sec (40 ms) 1 large box = 0.20 sec (200 ms) Normal PR interval: 120–200 ms (3–5 small boxes) Measure in multiple beats and take the average if rhythm is irregular. --- What Does PR Interval Represent? Atrial depolarization AV nodal conduction His bundle conduction It reflects AV nodal delay. --- PR Interval Abnormalities 1. Prolonged PR Interval (>200 ms) Diagnosis: First-degree AV block Causes: Increased vagal tone Drugs (β-blockers, CCBs, digoxin) Ischemia (especially inferior MI) Myocarditis Electrolyte imbalance Clinical significance: Usually benign May progre...

Systematic Evaluation of EP Maneuvers to Diagnose AVNRT During Electrophysiology Study (EPS)

Try to interpret the above Intracardiac tracing. Most will notice the very short VA time prior to VODP, which already argues strongly against AVRT.  Just before termination, there is full RV capture at 300ms, with the atria continuing independently at 335ms. This VA dissociation would be highly unusual in AVRT, as AVRT requires both atrial and ventricular participation to sustain the circuit. The tachycardia would not persist this long under these conditions if AVRT were the mechanism. It would either terminate immediately or the atria would be accelerated to the pacing cycle length prior to termination. If the tachycardia terminates without atrial acceleration, think AVNRT.  If the atria never depolarise to the pacing cycle length, atrial tachycardia is not possible. So the most likely diagnosis in above tracing is AVNRT Systematic Evaluation of EP Maneuvers to Diagnose AVNRT During Electrophysiology Study (EPS) --- Introduction Atrioventricular Nodal Reentrant Tachycardia (A...

Post Fascicular Ventricular Tachycardia (Belhassen VT)

Post Fascicular Ventricular Tachycardia (Belhassen VT) Introduction Post fascicular ventricular tachycardia (PFVT), commonly called fascicular VT or Belhassen VT, is a distinct form of idiopathic left ventricular tachycardia. It typically occurs in young patients without structural heart disease and is characteristically verapamil sensitive. Unlike scar-related VT seen in structural cardiomyopathy, PFVT originates from the specialized conduction system of the left ventricle—most often the posterior fascicle of the left bundle branch. --- Historical Background This arrhythmia was first clearly described and treated successfully with verapamil by Hein J. J. Wellens and later characterized by Menashe Belhassen, hence the term Belhassen tachycardia. --- Epidemiology Typically affects young males (15–40 years) Structurally normal heart Accounts for 10–15% of idiopathic VTs Often misdiagnosed as SVT with aberrancy --- Mechanism PFVT is a re-entry tachycardia involving the Purkinje system. Mo...